Search

Your search keyword '"oxysophocarpine"' showing total 33 results

Search Constraints

Start Over You searched for: Descriptor "oxysophocarpine" Remove constraint Descriptor: "oxysophocarpine"
Sorry, I don't understand your search. ×
33 results on '"oxysophocarpine"'

Search Results

1. Oxysophocarpine attenuates inflammatory osteolysis by modulating the NF-κb pathway and the reactive oxygen species-related Nrf2 signaling pathway.

2. Oxysophocarpine Prevents the Glutamate-Induced Apoptosis of HT–22 Cells via the Nrf2/HO–1 Signaling Pathway

Catalog

Books, media, physical & digital resources

3. Oxysophocarpine Prevents the Glutamate-Induced Apoptosis of HT-22 Cells via the Nrf2/HO-1 Signaling Pathway.

4. Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression

5. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis

6. Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression.

7. Neuroprotective Effect of Oxysophocarpine by Modulation of MAPK Pathway in Rat Hippocampal Neurons Subject to Oxygen–Glucose Deprivation and Reperfusion.

8. Oxysophocarpine suppresses TRAF6 level to ameliorate oxidative stress and inflammatory factors secretion in mice with dextran sulphate sodium (DSS) induced-ulcerative colitis.

9. Extraction and Separation of Oxysophocarpine from Sophora alopecuroides by Reverse Three-phase Membrane Cycle Method.

10. The Anticonvulsant and Neuroprotective Effects of Oxysophocarpine on Pilocarpine-Induced Convulsions in Adult Male Mice.

11. Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression

12. Oxysophocarpine inhibits airway inflammation and mucus hypersecretion through JNK/AP-1 pathway in vivo and in vitro.

13. Human microsomal cyttrochrome P450-mediated reduction of oxysophocarpine, an active and highly toxic constituent derived from Sophora flavescens species, and its intestinal absorption and metabolism in rat.

14. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis

15. Oxysophocarpine Ameliorates Carrageenan-induced Inflammatory Pain via Inhibiting Expressions of Prostaglandin E2 and Cytokines in Mice.

16. Matrine- and oxymatrine-imprinted monodisperse polymers prepared by precipitation polymerization and their applications for the selective extraction of matrine-type alkaloids from Sophora flavescens Aiton

17. Study on the oscillation dissolved behavior of oxysophocarpine in water

18. Pharmacokinetic study of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of Sophora flavescens Ait. extract by liquid chromatography tandem mass spectrometry

19. Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib.

20. IDENTIFICATION AND DETERMINATION OF THE CHEMICAL CONSTITUENTS IN A HERBAL PREPARATION, COMPOUND KUSHEN INJECTION, BY HPLC AND LC-DAD-MS/MS

21. Comparison of alkaloids in roots of cultivated and wild Sophora flavsecens

22. Evaluation analysis of alkaloids in seed of Sophora flavescens from Shanxi province and exploration of its utilization value

24. Oxysophocarpine protects airway epithelial cells against inflammation and apoptosis by inhibiting miR-155 expression.

25. Oxysophocarpine reduces oxidative stress and inflammation in tuberculosis-infected neutrophils and mouse lungs.

26. Sophora alopecuroides L.: An ethnopharmacological, phytochemical, and pharmacological review.

27. pKa determination of oxysophocarpine by reversed - phase high performance liquid chromatography

28. [Absorption mechanism of oxysophocarpine across Caco-2 cell monolayer mode]

29. Simultaneous determination of 7 alkaloid in Herba Sophorae Alopecuroidis by HPLC

30. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.

32. Oxysophocarpine inhibits lung injury induced by respiratory syncytial virus.

33. Oxysophocarpine reduces oxygen-glucose deprivation-induced microglial activation and injury.